Screener
GE HealthCare Technologies GEHC Equity Method Income
Equity Method Income at other companies
Other financials
Where this comes from
Reported directly by GE HealthCare Technologies in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.
The source filing: GE HealthCare Technologies’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 6:27 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001932393-26-000046
| Line item | For the three months ended June 30 / 2026 | For the three months ended June 30 / 2025 | For the six months ended June 30 / 2026 | For the six months ended June 30 / 2025 |
|---|---|---|---|---|
| Net financing income and investment income (loss) | $7 | $6 | $6 | $5 |
| Equity method income (loss) | — | 1 | (2) | 4 |
| Change in fair value of assumed obligations | (3) | (10) | (9) | (18) |
| Gain on remeasurement of NMP equity method investment(1) | — | — | — | 97 |
| Other items, net(2) | 18 | 2 | 64 | 11 |
| Total other income (expense) – net | $22 | $(1) | $58 | $98 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is GE HealthCare Technologies's equity method income?
- GE HealthCare Technologies (GEHC) reported equity method income of $0 in Q2 2026.
- How has GE HealthCare Technologies's equity method income changed year-over-year?
- GE HealthCare Technologies's equity method income decreased by 100.0% year-over-year, from $1M to $0.
- What does equity method income mean?
- The company's proportional share of net income or loss from unconsolidated affiliates and joint ventures accounted for under the equity method.
Ask your AI about GE HealthCare Technologies's equity method income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude